SCHEMBL2532957

SCHEMBL2532957

CCCCCCCCCC(O)C(C(=O)O)C(=O)CC(O)CCCCCCCC1(C2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 4/20 0.34
SELP P16109 2/20 0.32
SELL P14151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3710991 1.00 GPR84 (0.34) GPR84SELPSELL
SCHEMBL374296 1.00 GPR84 (0.34) GPR84SELPSELL
SCHEMBL2531505 1.00 GPR84 (0.34) GPR84SELPSELL
SCHEMBL18983979 1.00 GPR84 (0.34) GPR84SELPSELL
SCHEMBL8013415 0.80 GPR84 (0.42) GPR84SELPSELL
SCHEMBL3781567 0.80 GPR84 (0.42) GPR84SELPSELL
SCHEMBL17294503 0.80 GPR84 (0.42) GPR84SELPSELL
SCHEMBL14332067 0.80 GPR84 (0.42) GPR84SELPSELL
SCHEMBL14957946 0.80 GPR84 (0.42) GPR84SELPSELL
SCHEMBL10534787 0.80 GPR84 (0.42) GPR84SELPSELL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4204505-B1 POLISHING COMPOSITIONS AND METHODS OF USING THE SAME FUJIFILM ELECTRONIC MAT USA INC (US) 2025-11-05 EP disclosed
US-20240117270-A1 CLEANING COMPOSITIONS AND METHODS OF USE THEREOF FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2024-04-11 US disclosed
US-11884900-B2 Cleaning compositions and methods of use thereof FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2024-01-30 US disclosed
US-11807780-B2 Aqueous coatings containing biosurfactants as bio-adjuvants and methods for using same RHODIA OPERATIONS (FR) 2023-11-07 US disclosed
EP-4204506-A1 CLEANING COMPOSITIONS AND METHODS OF USE THEREOF FUJIFILM Electronic Materials U.S.A, Inc. (US) 2023-07-05 EP disclosed
EP-4204505-A1 POLISHING COMPOSITIONS AND METHODS OF USING THE SAME FUJIFILM Electronic Materials U.S.A, Inc. (US) 2023-07-05 EP disclosed
US-20220064577-A1 CLEANING COMPOSITIONS AND METHODS OF USE THEREOF FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2022-03-03 US disclosed
WO-2022046893-A1 POLISHING COMPOSITIONS AND METHODS OF USING THE SAME FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2022-03-03 WO disclosed
US-20220064487-A1 POLISHING COMPOSITIONS AND METHODS OF USING THE SAME FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2022-03-03 US disclosed
EP-3877470-A1 AQUEOUS COATINGS CONTAINING BIOSURFACTANTS AS BIO-ADJUVANTS AND METHODS FOR USING SAME RHODIA OPERATIONS (FR) 2021-09-15 EP disclosed
EP-2847285-A2 AQUEOUS COATINGS AND PAINTS INCORPORATING ONE OR MORE ANTIMICROBIAL BIOSURFACTANTS AND METHODS FOR USING SAME Rhodia Operations (FR) 2015-03-18 EP disclosed
US-20150051162-A1 METHOD FOR TREATING LOCALIZED FAT DEPOSITS RHAMNOPHARMA INC (US) 2015-02-19 US disclosed
US-8957129-B2 Aqueous coatings and paints incorporating one or more antimicrobial biosurfactants and methods for using same RHODIA OPERATIONS (FR) 2015-02-17 US disclosed
US-8765694-B2 Method for treating obesity RHAMNOPHARMA INC. (US) 2014-07-01 US disclosed
US-20140080771-A1 METHOD FOR TREATING RHINITIS AND SINUSITIS BY RHAMNOLIPIDS RHAMNOPHARMA INC. (US) 2014-03-20 US disclosed
WO-2014027249-A2 AQUEOUS COATINGS AND PAINTS INCORPORATING ONE OR MORE ANTIMICROBIAL BIOSURFACTANTS AND METHODS FOR USING SAME RHODIA OPERATIONS (FR) 2014-02-20 WO disclosed
US-8592381-B2 Method for treating rhinitis and sinusitis by rhamnolipids RHAMNOPHARMA INC. (US) 2013-11-26 US disclosed
US-20130310330-A1 METHOD FOR TREATING OBESITY LEIGHTON, ANTON 2013-11-21 US disclosed
US-20130296461-A1 AQUEOUS COATINGS AND PAINTS INCORPORATING ONE OR MORE ANTIMICROBIAL BIOSURFACTANTS AND METHODS FOR USING SAME RHODIA OPERATIONS (FR) 2013-11-07 US disclosed
US-20110257115-A1 METHOD FOR TREATING RHINITIS AND SINUSITIS BY RHAMNOLIPIDS LEIGHTON, ANTON 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051162-A1 METHOD FOR TREATING LOCALIZED FAT DEPOSITS FABP4, LIPA, LIPC GPR84 760/4885SELP 2580/4885SELL 2430/4885
US-20110257115-A1 METHOD FOR TREATING RHINITIS AND SINUSITIS BY RHAMNOLIPIDS CMA1, HRH2, LIPA GPR84 333/4885SELP 2419/4885SELL 700/4885
US-20130310330-A1 METHOD FOR TREATING OBESITY FABP4, LIPA, LIPC GPR84 442/4885SELP 2684/4885SELL 2842/4885
US-20140080771-A1 METHOD FOR TREATING RHINITIS AND SINUSITIS BY RHAMNOLIPIDS CMA1, HRH2, LIPA GPR84 333/4885SELP 2419/4885SELL 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.